Fusion Antibodies plc FAB.L Stock
Fusion Antibodies plc Price Chart
Fusion Antibodies plc FAB.L Financial and Trading Overview
| Fusion Antibodies plc stock price | 4.05 GBP |
| Previous Close | 8.5 GBP |
| Open | 0 GBP |
| Bid | 7.75 GBP x 0 |
| Ask | 0 GBP x 0 |
| Day's Range | 0 - 0 GBP |
| 52 Week Range | 0 - 110 GBP |
| Volume | 641.34K GBP |
| Avg. Volume | 1.01M GBP |
| Market Cap | 4.83M GBP |
| Beta (5Y Monthly) | 0.541762 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.09 GBP |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
FAB.L Valuation Measures
| Enterprise Value | 1.35M GBP |
| Trailing P/E | N/A |
| Forward P/E | -0.0325 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.1444238 |
| Price/Book (mrq) | 82.07071 |
| Enterprise Value/Revenue | 0.319 |
| Enterprise Value/EBITDA | -0.953 |
Trading Information
Fusion Antibodies plc Stock Price History
| Beta (5Y Monthly) | 0.541762 |
| 52-Week Change | -81.52% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 110 GBP |
| 52 Week Low | 0 GBP |
| 50-Day Moving Average | 26.47 GBP |
| 200-Day Moving Average | 40.97 GBP |
FAB.L Share Statistics
| Avg. Volume (3 month) | 1.01M GBP |
| Avg. Daily Volume (10-Days) | 3.43M GBP |
| Shares Outstanding | 59.45M |
| Float | 23.07M |
| Short Ratio | N/A |
| % Held by Insiders | 33.41% |
| % Held by Institutions | 39.51% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2022 |
| Most Recent Quarter (mrq) | September 30, 2022 |
| Next Fiscal Year End | March 31, 2023 |
Profitability
| Profit Margin | -41.032% |
| Operating Margin (ttm) | -45.77% |
| Gross Margin | 44.34% |
| EBITDA Margin | -33.45% |
Management Effectiveness
| Return on Assets (ttm) | -25.81% |
| Return on Equity (ttm) | -50.80% |
Income Statement
| Revenue (ttm) | 4.22M GBP |
| Revenue Per Share (ttm) | 0.16 GBP |
| Quarterly Revenue Growth (yoy) | -23.69% |
| Gross Profit (ttm) | 2.47M GBP |
| EBITDA | -1412000 GBP |
| Net Income Avi to Common (ttm) | -1732000 GBP |
| Diluted EPS (ttm) | -0.08 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.2M GBP |
| Total Cash Per Share (mrq) | 0.05 GBP |
| Total Debt (mrq) | 333K GBP |
| Total Debt/Equity (mrq) | 12.95 GBP |
| Current Ratio (mrq) | 2.841 |
| Book Value Per Share (mrq) | 0.099 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -574000 GBP |
| Levered Free Cash Flow (ttm) | -492625 GBP |
Profile of Fusion Antibodies plc
| Country | United Kingdom |
| State | N/A |
| City | Belfast |
| Address | 1 Springbank Road |
| ZIP | BT17 0QL |
| Phone | 44 28 9043 2800 |
| Website | https://www.fusionantibodies.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 55 |
Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. The company offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services. It serves pharmaceutical, biotech, and diagnostic companies. The company has a collaboration partnership with Celonic AG. Fusion Antibodies plc was incorporated in 2000 and is headquartered in Belfast, the United Kingdom.
Q&A For Fusion Antibodies plc Stock
What is a current FAB.L stock price?
Fusion Antibodies plc FAB.L stock price today per share is 4.05 GBP.
How to purchase Fusion Antibodies plc stock?
You can buy FAB.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Fusion Antibodies plc?
The stock symbol or ticker of Fusion Antibodies plc is FAB.L.
Which industry does the Fusion Antibodies plc company belong to?
The Fusion Antibodies plc industry is Biotechnology.
How many shares does Fusion Antibodies plc have in circulation?
The max supply of Fusion Antibodies plc shares is 953.66K.
What is Fusion Antibodies plc Price to Earnings Ratio (PE Ratio)?
Fusion Antibodies plc PE Ratio is now.
What was Fusion Antibodies plc earnings per share over the trailing 12 months (TTM)?
Fusion Antibodies plc EPS is -0.09 GBP over the trailing 12 months.
Which sector does the Fusion Antibodies plc company belong to?
The Fusion Antibodies plc sector is Healthcare.